导航

| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -16.06% | 940/1050 |
| 近一周 | -2.13% | 732/1104 |
| 近一月 | -4.69% | 738/1103 |
| 近一季 | -0.22% | 305/1092 |
| 近半年 | -11.47% | 816/1070 |
| 近一年 | -24.31% | 949/1018 |
| 近两年 | 19.58% | 785/926 |
| 近三年 | 5.09% | 627/834 |
| 成立以来 | 7.38% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-11.49% 1025/1070 |
-6.51% 832/1101 |
- - |
- - |
| 2025 | 24.75% 584/1065 |
14.77% 55/1014 |
6.21% 230/1038 |
16.90% 699/1050 |
-12.46% 942/1065 |
| 2024 | 16.48% 141/1011 |
-1.41% 396/960 |
5.70% 78/983 |
15.65% 193/991 |
-3.35% 559/1011 |
| 2023 | -23.58% 752/952 |
-6.02% 817/880 |
-8.27% 702/895 |
-1.11% 120/915 |
-10.36% 869/952 |
| 2022 | -26.75% 547/867 |
-20.78% 559/773 |
7.06% 403/806 |
-25.37% 800/845 |
15.71% 35/867 |
| 2021 | -7.14% 452/740 |
-4.07% 307/580 |
13.82% 260/659 |
-7.08% 419/704 |
-8.47% 643/740 |
| 2020 | 26.35% 361/554 |
-10.84% 389/419 |
19.57% 291/466 |
5.19% 361/517 |
12.67% 264/554 |
| 2019 | 17.33% 336/410 |
- - |
- - |
- - |
- - |
| 2018 | -18.44% 52/349 |
- - |
- - |
- - |
- - |
| 2017 | 35.27% 21/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 工银沪港深股票A VS. 东吴新产业精选股票A(580008) |